Correlation Between Partners Value and Pfizer

Can any of the company-specific risk be diversified away by investing in both Partners Value and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Partners Value and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Partners Value Investments and Pfizer Inc CDR, you can compare the effects of market volatilities on Partners Value and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Partners Value with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Partners Value and Pfizer.

Diversification Opportunities for Partners Value and Pfizer

-0.7

Correlation Coefficient

Partners Value  Pfizer

Excellent diversification

The 3 months correlation between Partners and Pfizer is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Partners Value Investments and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Partners Value is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Partners Value Investments are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Partners Value i.e., Partners Value and Pfizer go up and down completely randomly.

Pair Corralation between Partners Value and Pfizer

Assuming the 90 days trading horizon Partners Value Investments is expected to generate 1.11 times more return on investment than Pfizer. However, Partners Value is 1.11 times more volatile than Pfizer Inc CDR. It trades about 0.61 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about 0.07 per unit of risk. If you would invest  13,000  in Partners Value Investments on September 23, 2024 and sell it today you would earn a total of  3,499  from holding Partners Value Investments or generate 26.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Partners Value Investments  vs.  Pfizer Inc CDR

Partners Value Inves

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Partners Value Investments are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Partners Value sustained solid returns over the last few months and may actually be approaching a breakup point.

Pfizer Inc CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Partners Value and Pfizer

The main advantage of trading using opposite Partners Value and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Partners Value position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind Partners Value Investments and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.